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This section features outstanding photographs of clinical materials selected for their ed-
ucational value or message, or possibly their rarity. The images are accompanied by
brief case reports (limit 2 typed pages, 4 references). Our readers are invited to sumit
items for consideration.Malignant fibrous histiocytoma of the
greater omentum
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Medicine, Naples, ItalyFig 1. Intra-operative view of malignant fibrous histiocy-
toma of greater omentum.A 55-YEAR-OLD CAUCASIAN WOMAN was admitted to
our hospital complaining of abdominal pain. Her
past medical history was not significant and she
had no previous history of abdominal trauma.
On physical examination a firm, not-fixed mass
about 20 cm in diameter was found in the upper
abdomen. Standard blood tests and chest x-rays
were normal. Carcinoembryonic antigen, carbohy-
drate antigen 19-9, and a-fetoprotein levels were
normal with only CA125 being increased at 201.9
U/mL (normal, <35 U/mL). Upper gastrointesti-
nal endoscopy showed an extrinsic impression on
greater curvature of the stomach with no intralu-
minal abnormality. Colonoscopy was normal. Ab-
dominal computed tomography showed a solid,
large mass occupying the entire upper abdomen
with heterogeneous enhancement and some calci-
fied areas. Neither ascites nor uterine or ovarian
abnormalities were detected. At laparotomy, a
huge tumor originating from the greater omen-
tum was found with no peritoneal spreading or in-
vasion of neighbouring organs (Fig 1). The massd for publication October 1, 2009.
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016/j.surg.2009.10.001was removed along with the entire greater omen-
tum. The patient recovered uneventfully. At pa-
thology the solid encapsulated specimen (19 3
14 3 9 cm) was pleomorphic and composed of
fibroblasts, histiocyte-like cells, and pleomorphic
giant cells (Fig 2, A), arranged in a storiform pat-
tern. Immunohistochemical stains were positive
for vimentin (Fig 2, B), CD68 (Fig 2, C), and neg-
ative for desmin (Fig 2, D). Based on these results,
a definitive diagnosis of a storiform-pleomorphic
variant of malignant fibrous histiocytoma
(MFH) was made. The patient underwent mesna-
doxorubicine-iphosphamide-deticene–based adjuvantSURGERY 455
Fig 2. Histopathologic examination shows a pleomorphic tumor composed of fibroblasts, myofibroblasts, and histio-
cyte-like cells arranged in a storiform pattern (A, stain: hematoxylin and eosin; original magnification, 3 150). The tu-
mor cells are diffusely positive for vimentin and CD68 but negative for desmin. (B, stain: vimentin; original
magnification, 3 150; C, stain: CD68; original magnification, 3 150; D, stain: desmin; original magnification, 3 250.)
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456 Addeo et alchemotherapy for 6 months. At 3 years follow-up,
the patient showed no signs of recurrence.
DISCUSSION
Malignant fibrous histiocytoma is a soft tissue
neoplasm, arising from primitive mesenchymal
cells demonstrating both histiocytic and fibroblas-
tic differentiation. It represents the most common
soft tissue sarcoma of the middle and late adult-
hood.1 The most common sites involved are the
lower (50%) and upper (25%) extremities fol-
lowed by the retroperitoneum (15%). Five histo-
logic MFH subtypes have been described:
pleomorphic storiform (65%), myxoid (15%), gi-
ant cell (10%), inflammatory (8%), and angioma-
toid (2%). Malignant fibrous histiocytoma is an
aggressive sarcoma; tumor location, size, and histo-
logic grade directly influence prognosis. Five-year
survival for tumors <5 cm is 82%. This figure falls
to 68% for 5- to 10-cm tumors, and 51% for tumors
>10 cm. Metastases occur most commonly to the
lungs (90%), lymph nodes (12%), bone (8%),
and liver (1%).2,3 Although MFH may arise from
the supporting structures of various organs, the
greater omentum is an extremely rare primary lo-
calization. The greater omentum covers a large
area of the abdominal cavity, and omental tumorsmay occur in any part of the abdomen and mimic
tumors of any tissue or organ. These tumors may
reach large dimensions within the compliant ab-
dominal cavity. Pre-operative imaging workup
does not yield a confident preoperative diagnosis
of primary omental tumors, but does facilitate
the elimination of other potential primary tu-
mors, which may be responsible for omental
metastases. For this same reason, upper GI en-
doscopy and colonoscopy are mandatory to elim-
inate a digestive cancer metastatic to the greater
omentum. Although patients with primary tu-
mors located in the greater omentum may be
asymptomatic, abdominal discomfort (as in the
present case), nausea, weight loss, and a palpable
abdominal mass are common. Operative explora-
tion may be necessary to provide a definitive
diagnosis.
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